http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2223779-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-15 |
| filingDate | 2002-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a187e3a0fa34560a16c86829feb24dd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9648081affd3669cf8d4b8c30189146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9e202ccbf943f201d4a51385f38747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bb7e798646ae8d607cfaa8532ff4260 |
| publicationDate | 2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2223779-C1 |
| titleOfInvention | Correction therapy method for applying mammary gland carcinoma complex treatment |
| abstract | FIELD: medicine. SUBSTANCE: method involves administering a biologically active additive two days before chemotherapy beginning at a dose of 10-15 ml twice a day. Leukocyte number in blood and transaminases level are determined before and after administering the chemotherapy course. Leukocyte number being below 3,3×10 9 /l 3,0×10 9 /l and/or transaminases level being 1.5-2 times as high as a norm, the preparation dose is doubled. The preparation is diluted with 0.9% physiological salt solution. EFFECT: enhanced effectiveness of treatment; reduced risk of complications. |
| priorityDate | 2002-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.